Keywords: |
gene mutation; cancer risk; cancer incidence; laparoscopy; salpingooophorectomy; ovarian neoplasms; genetic predisposition to disease; ovary cancer; peritoneum cancer; peritoneal neoplasms; ovariectomy; morbidity; cancer screening; editorial; brca2 protein; postoperative complication; ovary; patient care; genes, brca1; genes, brca2; surgical risk; hormonal therapy; vaginal hysterectomy; uterine tube carcinoma; fallopian tube neoplasms; genetic predisposition; gynecologic cancer; gynecologic surgery; germ-line mutation; hormone substitution; uterus carcinoma; harm reduction; humans; human; female; priority journal
|